endo-BCN-PEG2-Val-Cit-PAB-MMAE is a synthetic linker-payload which may be applied for the creation of antibody drug conjugates (ADCs). It contains a chemically labile Val-Cit dipeptide and a MMAE payload. The MMAE is a synthetic antineoplastic agent that can be attached to a monoclonal antibody (mAb). The BCN group reacts with azide-tagged compounds or biomolecules.
Usually ships within 24 hours.